The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis
- PMID: 33638772
- DOI: 10.1007/s10741-021-10091-z
The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis
Abstract
Pacing-induced cardiomyopathy (PICM) or heart failure accompanied with chronic right ventricular pacing (CRVP-HF) has no established treatments. We aimed to carry out a meta-analysis of published studies about the therapeutic effects of the upgrade to cardiac resynchronization therapy (CRT) in patients of PICM/CRVP-HF. The PUBMED, EMBASE, MEDLINE, OVID databases, and Cochrane Library were systemically searched for relevant publications. Data about the improvements of left ventricular ejection fraction (LVEF), NYHA functional class (NYHA-FC), and the CRT response rate was extracted and synthesized. Mean difference (MD), odds ratio, and standard mean difference (SMD) with 95% confidence interval (CI) were calculated as the effect size by both fixed and random effect models. We included sixteen studies (four about PICM and twelve about CRVP-HF). The total sample size of PICM/CRVP-HF patients was 924. Upgrade to CRT improved the LVEF by 10.87% (95%CI, 8.90 to 12.84%) and reduce the NYHA-FC by around one class (MD, -1.25; 95%CI, -1.43 to -1.06) in PICM/CRVP-HF patients overall. Upgrade to CRT seemed to improve LVEF no less than de-novo CRT (SMD 0.24; 95%CI 0.05 to 0.43; P < 0.05). This meta-analysis suggested that upgrade CRT could improve the cardiac function in PICM/CRVP-HF patients. This strategy may be considered in these patients but require more evidence about the efficacy and procedure-related complications from prospective studies or randomized controlled trials.
Keywords: Cardiac resynchronization therapy; Heart failure; Pacing-induced cardiomyopathy; Right ventricular pacing; Upgrade.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.
Similar articles
-
Reversal of Pacing-Induced Cardiomyopathy Following Cardiac Resynchronization Therapy.JACC Clin Electrophysiol. 2018 Feb;4(2):168-177. doi: 10.1016/j.jacep.2017.10.002. Epub 2017 Nov 15. JACC Clin Electrophysiol. 2018. PMID: 29749933
-
Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function.Heart Rhythm. 2016 Dec;13(12):2272-2278. doi: 10.1016/j.hrthm.2016.09.027. Heart Rhythm. 2016. PMID: 27855853
-
Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy.Yonsei Med J. 2017 Jul;58(4):703-709. doi: 10.3349/ymj.2017.58.4.703. Yonsei Med J. 2017. PMID: 28540981 Free PMC article.
-
Effectiveness of conduction system pacing for cardiac resynchronization therapy: A systematic review and network meta-analysis.J Cardiovasc Electrophysiol. 2023 Nov;34(11):2342-2359. doi: 10.1111/jce.16086. Epub 2023 Sep 28. J Cardiovasc Electrophysiol. 2023. PMID: 37767743 Review.
-
Cardiac resynchronization therapy is appropriate for all patients requiring chronic right ventricular pacing: the pro perspective.Card Electrophysiol Clin. 2015 Sep;7(3):433-44. doi: 10.1016/j.ccep.2015.05.013. Epub 2015 Jul 3. Card Electrophysiol Clin. 2015. PMID: 26304523 Review.
Cited by
-
Conduction system pacing upgrade versus biventricular pacing on pacemaker-induced cardiomyopathy: a retrospective observational study.Front Physiol. 2024 Jul 23;15:1355696. doi: 10.3389/fphys.2024.1355696. eCollection 2024. Front Physiol. 2024. PMID: 39108542 Free PMC article.
-
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction.J Interv Card Electrophysiol. 2025 Jan;68(1):111-116. doi: 10.1007/s10840-024-01882-z. Epub 2024 Aug 17. J Interv Card Electrophysiol. 2025. PMID: 39153133
-
Conduction System Pacing for Cardiac Resynchronization Therapy.J Cardiovasc Dev Dis. 2023 Oct 31;10(11):448. doi: 10.3390/jcdd10110448. J Cardiovasc Dev Dis. 2023. PMID: 37998506 Free PMC article. Review.
-
The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy.Heart Rhythm O2. 2023 Jan 25;4(4):225-231. doi: 10.1016/j.hroo.2023.01.004. eCollection 2023 Apr. Heart Rhythm O2. 2023. PMID: 37124556 Free PMC article.
-
Rate-Responsive Cardiac Pacing: Technological Solutions and Their Applications.Sensors (Basel). 2023 Jan 27;23(3):1427. doi: 10.3390/s23031427. Sensors (Basel). 2023. PMID: 36772467 Free PMC article. Review.
References
-
- Askenazi J, Alexander JH, Koenigsberg DI et al (1984) Alteration of left ventricular performance by left bundle branch block simulated with atrioventricular sequential pacing. Am J Cardiol 53:99–104. https://doi.org/10.1016/0002-9149(84)90691-x - DOI - PubMed
-
- Tantengco MV, Thomas RL, Karpawich PP (2001) Left ventricular dysfunction after long-term right ventricular apical pacing in the young. J Am Coll Cardiol 37:2093–2100. https://doi.org/10.1016/s0735-1097(01)01302-x - DOI - PubMed
-
- Merchant FM, Hoskins MH, Musat DL et al (2017) Incidence and time course for developing heart failure with high-burden right ventricular pacing. Circ Cardiovasc Qual Outcomes 10:1–11. https://doi.org/10.1161/CIRCOUTCOMES.117.003564 - DOI
-
- Dreger H, Maethner K, Bondke H et al (2012) Pacing-induced cardiomyopathy in patients with right ventricular stimulation for >15 years. Europace 14:238–242. https://doi.org/10.1093/europace/eur258 - DOI - PubMed
-
- Merchant FM, Mittal S (2020) Pacing induced cardiomyopathy. J Cardiovasc Electrophysiol 31:286–292. https://doi.org/10.1111/jce.14277 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous